I think MI rate in both groups will be key primary endpoint to look at - with modern ER medical treatments, if you get to the hospital on time you're not likely to have a fatal MI - and JELIS had very few of them. Doesn't matter, since IMO stopping the first MI is the most important thing we need to show - no drug has shown success in stopping the first MI, standalone or as statin add-on.